We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
1376
Tectonic Therapeutic
TECX
$562M
-7
Closed
CMRX
1377
DELISTED
Chimerix, Inc.
CMRX
-253
Closed
SYRS
1378
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-10
Closed
ME
1379
DELISTED
23andMe Holding Co
ME
-48
Closed -$3K
RBCP
1380
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
-50,000
Closed -$5.16M
TBIO
1381
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
-5
Closed
TWOU
1382
DELISTED
2U Inc
TWOU
-30
Closed -$6K
OMIC
1383
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
-7
Closed -$1K
MRNS
1384
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$0 ﹤0.01%
58
EIGR
1385
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$0 ﹤0.01%
2
GMDA
1386
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-93
Closed
CYT
1387
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-103
Closed
GRCL
1388
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$0 ﹤0.01%
146
ICVX
1389
DELISTED
Icosavax, Inc. Common Stock
ICVX
-114
Closed
AMTI
1390
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
-132
Closed
PRTK
1391
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-86
Closed
SURF
1392
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-77
Closed
HARP
1393
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-5
Closed
PCGU
1394
DELISTED
PG&E Corporation
PCGU
-50,000
Closed -$5.75M
SPPI
1395
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-321
Closed
EVLO
1396
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$0 ﹤0.01%
8
TCRR
1397
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-131
Closed
JNCE
1398
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-75
Closed
PEAR
1399
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
-12,737
Closed -$26K
RUBY
1400
DELISTED
Rubius Therapeutics, Inc
RUBY
-307
Closed

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.